Add to favorites:
Share:
This call focuses on advancing innovative interventions for mental, behavioural, and neurodevelopmental disorders, including severe depression, schizophrenia, PTSD, and others. Projects aim to deliver safer, more effective therapies and complementary non-pharmaceutical approaches. The call emphasizes developing personalized, multidisciplinary solutions leveraging state-of-the-art technologies like AI and wearables while adhering to ethical and inclusive principles. Collaboration between academia, industry, patient organizations, and regulators is encouraged, with a focus on rigorous clinical studies, data integration, and stakeholder engagement.
Opening: 22-05-2025
Deadline(s): 18-09-2025
Data provided by Kooperationsstelle Wissenschaft
This funding opportunity represents a pre-agreed draft that has not yet been officially approved by the European Commission. The final, approved version is expected to be published in the first quarter of 2025. This draft is provided for informational purposes and may be used to preliminarily form consortia and develop project ideas, but it is offered without any guarantees or warranties.
Expected Outcome
- Effective use of state-of-the-art tools and knowledge for innovative interventions.
- Strengthened collaboration and data exchange across EU and associated countries.
- Broad use of relevant databases adhering to FAIR principles.
- Awareness among stakeholders about research advancements and implementation needs.
- Enhanced patient and caregiver engagement to benefit from developed interventions.
Scope
- Development of innovative and safe therapeutic solutions for mental, behavioural, and neurodevelopmental disorders.
- Complementary multidisciplinary approaches such as neurostimulation, neuroimaging, psychotherapy, and digital interventions.
- Integration of advanced technologies, including AI and wearables, to monitor efficacy and manage disorders.
- Use and adherence to FAIR principles in data management and utilization of existing biobanks and registries.
- Stakeholder engagement to design patient-centered interventions and ensure ethical and inclusive practices.